SECTION 1. Chapter 32A of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by inserting after section 17R the following section:-

Section 17S. The commission shall provide to any active or retired employee of the commonwealth or spouse/dependent who is insured under the group insurance commission coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.

SECTION 2. Chapter 175 is hereby amended by inserting after section 47NN the following section:-

Section 47OO. Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.

SECTION 3. Chapter 176A is hereby amended by inserting after Section 8OO the following section:-

Section 8PP. Any contract between a subscriber and a corporation under an individual or group hospital service plan delivered, issued or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.

SECTION 4. Chapter 176B is hereby amended by inserting after section 4OO the following section:-

Section 4PP. Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.

SECTION 5. Chapter 176G is hereby amended by inserting after Section 4GG the following section:-

Section 4HH. Any individual or group health maintenance contract shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.